Grace Therapeutics Inc. (GRCE)
NASDAQ: GRCE
· Real-Time Price · USD
3.11
0.10 (3.32%)
At close: Oct 15, 2025, 3:59 PM
3.08
-1.06%
After-hours: Oct 15, 2025, 04:23 PM EDT
3.32% (1D)
| Bid | 2.99 |
| Market Cap | 43.05M |
| Revenue (ttm) | 8K |
| Net Income (ttm) | -10.31M |
| EPS (ttm) | -0.76 |
| PE Ratio (ttm) | -4.1 |
| Forward PE | -2.26 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 3.24 |
| Volume | 198,991 |
| Avg. Volume (20D) | 81,668 |
| Open | 2.98 |
| Previous Close | 3.01 |
| Day's Range | 2.98 - 3.22 |
| 52-Week Range | 1.75 - 4.97 |
| Beta | 1.00 |
| Ex-Dividend Date | n/a |
About GRCE
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol GRCE
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for GRCE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts8 months ago
+8.33%
Grace Therapeutics shares are trading higher after...
Unlock content with
Pro Subscription
